Whether You Smoke It, Toke It or Drink It - These Stocks are Heating Up

Date : 06/11/2019 @ 1:05PM
Source :InvestorsHub NewsWire
Stock : Cv Sciences, Inc. (QB) (CVSI)
Quote : 2.91  -0.13 (-4.28%) @ 3:03PM
CV Sciences, Inc. share price Chart

Whether You Smoke It, Toke It or Drink It - These Stocks are Heating Up

New York, NY -- June 11, 2019 -- InvestorsHub NewsWire -- via TradersNewsSource.com -- The cannabis market, and its peripheral industries are still creating interest to investors and there are some companies that seen poised for an increase in share value.


22nd Century Group, Inc. (NYSE: XXII) has entered into a worldwide strategic research and development agreement with KeyGene NV, a global leader in plant research involving high-value genetic traits and increased crop yields. This exclusive, worldwide collaboration will focus on the development of hemp/cannabis plants with exceptional cannabinoid profiles for medical and therapeutic use.


While their main business has been the development of alcohol brands, International Spirits & Beverage Group, Inc. (OTC: ISBG) formed a strategic partnership with Cannabisfuse.net, an emerging leader in the affiliate marketing industry for the cannabis, hemp, and CBD products marketplace. They will be a feature brand for all those who flow through the Cannabisfuse.net site for products, services, and news related to cannabis, hemp, and CBD.

What events are making these stock HOT right now? See our full report READ MORE
Copy and paste to browser may be required – https://tradersnewssource.com/xxii-isbg-amfe-cvsi/


Amfil Technologies Inc. (OTC: AMFE), and its subsidiary GRO3, have received two purchase orders for its ozone-based antimicrobial technologies from Vessl Inc., the owners of Kalvara, for use in their cannabis-infused beverage production facilities. GRO3 will be supplying EcoPrO3-10SS Ozone Side Stream Systems, which will be integrated into the facilities for the purposes of providing an all-natural sanitization and anti-microbial solution throughout the production process.

The FDA has opened hearings regarding CBD and CV Sciences, Inc. (OTCQB: CVSI) is at the forefront recently giving the FDA a presentation of company data on CBD. The recent presentation focused on the importance of identifying and separately regulating different CBD product categories including drugs, foods and dietary supplements.

 The Company focuses on developing and commercializing proprietary prescription drugs utilizing synthetic cannabidiol (CBD) as the active pharmaceutical ingredient.


Our full comprehensive report on these companies is available with no obligation READ MORE
Copy and paste to browser may be required –  https://tradersnewssource.com/xxii-isbg-amfe-cvsi/
 

  Disclosure
 
Traders News Source LLC (TNS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering small and micro-cap equity markets. TNS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE, NASDAQ and OTC exchanges. The other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
 
TNS LLC has not been compensated; directly or indirectly; for producing or publishing this document.
 
PRESS RELEASE PROCEDURES
 
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a chartered financial analyst, for further information on analyst credentials, please email editor@tradersnewssource.com. TNS LLC provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written, and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author per the procedures outlined by TNS. TNS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents, or reports. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
 
NO WARRANTY
 
TNS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake, or shortcoming. No liability is accepted whatsoever for any direct, indirect, or consequential loss arising from the use of this document. TNS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, TNS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
 
NOT AN OFFERING
 
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://tradersnewssource.com/.
 
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer be featured on our coverage list, contact us via email at: editor@tradersnewssource.com
 
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


CONTACT: editor@tradersnewssource.com
SOURCE: Traders News Source

CV Sciences, Inc. (USOTC:CVSI)
Historical Stock Chart

1 Year : From Sep 2018 to Sep 2019

Click Here for more CV Sciences, Inc. Charts.

CV Sciences, Inc. (USOTC:CVSI)
Intraday Stock Chart

Today : Wednesday 18 September 2019

Click Here for more CV Sciences, Inc. Charts.

Latest CVSI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20190918 14:19:53